Replies to post #22244 on Revive Therapeutics Ltd (RVVTF)

[RioDad]

A vote with the DSMB maybe scheduled and no data released.
There are no rules around releasing data.

In the investor deck, it states the Bucillamine study will wrap up after March 1st.

[ragstorum]

Agreed, Reiko. They have to follow right procedure
to make sure the EUA application isn't delayed or turned down.
Revive may release other PR before phase3 results or EUA news?

[hotmeat]

Agreed...releasing official Trial data would definitely cast a shadow of unprofessionalism on RVV management as it would be viewed purely as an attempt to influence the pps.

As far as I'm aware, large Pharmaceutical companies DO NOT release specifics about their Trials until after it's been reviewed/approved by the FDA or other regulatory bodies.